198 related articles for article (PubMed ID: 23761553)
1. Contrast-enhanced US quantitatively detects changes of tumor perfusion in a murine breast cancer model during adriamycin chemotherapy.
Wang JW; Cao LH; Han F; Zheng W; Chen Y; Li AH; Zhou JH
Acta Radiol; 2013 Oct; 54(8):882-8. PubMed ID: 23761553
[TBL] [Abstract][Full Text] [Related]
2. Assessment of early tumor response to cytotoxic chemotherapy with dynamic contrast-enhanced ultrasound in human breast cancer xenografts.
Wang JW; Zheng W; Liu JB; Chen Y; Cao LH; Luo RZ; Li AH; Zhou JH
PLoS One; 2013; 8(3):e58274. PubMed ID: 23469274
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of tumor blood flow changes in a murine breast cancer model after adriamycin chemotherapy using contrast-enhanced destruction-replenishment sonography.
Wang JW; Zheng W; Chen Y; Cao LH; Luo RZ; Li AH; Zhou JH
J Ultrasound Med; 2013 Apr; 32(4):683-90. PubMed ID: 23525395
[TBL] [Abstract][Full Text] [Related]
4. Dose-response relationship in cisplatin-treated breast cancer xenografts monitored with dynamic contrast-enhanced ultrasound.
Chen Y; Han F; Cao LH; Li C; Wang JW; Li Q; Zheng W; Guo ZX; Li AH; Zhou JH
BMC Cancer; 2015 Mar; 15():136. PubMed ID: 25884471
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced gray-scale ultrasound for quantitative evaluation of tumor response to chemotherapy: preliminary results with a mouse hepatoma model.
Zhou JH; Cao LH; Zheng W; Liu M; Han F; Li AH
AJR Am J Roentgenol; 2011 Jan; 196(1):W13-7. PubMed ID: 21178025
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Evaluation of Combretastatin A4 Phosphate Early Efficacy in a Tumor Model with Dynamic Contrast-Enhanced Ultrasound.
Zhang P; Chen Y; Liu J; Yang Y; Lv Q; Wang J; Zhang L; Xie M
Ultrasound Med Biol; 2018 Apr; 44(4):840-852. PubMed ID: 29395676
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasonic parametric perfusion imaging in the evaluation of antiangiogenic tumor treatment.
Zhou JH; Zheng W; Cao LH; Liu M; Luo RZ; Han F; Wu PH; Li AH
Eur J Radiol; 2012 Jun; 81(6):1360-5. PubMed ID: 21345633
[TBL] [Abstract][Full Text] [Related]
8. Ultrasonic spectrum analysis for in vivo characterization of tumor microstructural changes in the evaluation of tumor response to chemotherapy using diagnostic ultrasound.
Lin CY; Cao LH; Wang JW; Zheng W; Chen Y; Feng ZZ; Li AH; Zhou JH
BMC Cancer; 2013 Jun; 13():302. PubMed ID: 23800247
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization.
Pitre-Champagnat S; Leguerney I; Bosq J; Peronneau P; Kiessling F; Calmels L; Coulot J; Lassau N
Invest Radiol; 2015 Apr; 50(4):212-7. PubMed ID: 25275834
[TBL] [Abstract][Full Text] [Related]
10. Super-Resolution Ultrasound Imaging for Monitoring the Therapeutic Efficacy of a Vascular Disrupting Agent in an Animal Model of Breast Cancer.
Hoyt K
J Ultrasound Med; 2024 Jun; 43(6):1099-1107. PubMed ID: 38411352
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound imaging of breast tumor perfusion and neovascular morphology.
Hoyt K; Umphrey H; Lockhart M; Robbin M; Forero-Torres A
Ultrasound Med Biol; 2015 Sep; 41(9):2292-302. PubMed ID: 26116159
[TBL] [Abstract][Full Text] [Related]
12. Monitoring parotid gland tumors with a new perfusion software for contrast-enhanced ultrasound.
Klotz LV; Ingrisch M; Eichhorn ME; Niemoeller O; Siedek V; Gürkov R; Clevert DA
Clin Hemorheol Microcirc; 2014; 58(1):261-9. PubMed ID: 25339101
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic tumor treatment: noninvasive monitoring with contrast pulse sequence imaging for contrast-enhanced grayscale ultrasound.
Zhou J; Zheng W; Cao L; Liu M; Han F; Li A
Acad Radiol; 2010 May; 17(5):646-51. PubMed ID: 20223684
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.
Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y
Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551
[TBL] [Abstract][Full Text] [Related]
15. Quantitative perfusion analysis in pancreatic contrast enhanced ultrasound (DCE-US): a promising tool for the differentiation between autoimmune pancreatitis and pancreatic cancer.
Vitali F; Pfeifer L; Janson C; Goertz RS; Neurath MF; Strobel D; Wildner D
Z Gastroenterol; 2015 Oct; 53(10):1175-81. PubMed ID: 26480053
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced ultrasound using real-time contrast harmonic imaging in invasive breast cancer: comparison of enhancement dynamics with three different doses of contrast agent.
Saracco A; Szabó BK; Aspelin P; Leifland K; Tánczos E; Wilczek B; Axelsson R
Acta Radiol; 2015 Jan; 56(1):34-41. PubMed ID: 24445092
[TBL] [Abstract][Full Text] [Related]
17. Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases.
Merz M; Komljenovic D; Semmler W; Bäuerle T
Invest Radiol; 2012 Jul; 47(7):422-9. PubMed ID: 22659593
[TBL] [Abstract][Full Text] [Related]
18. Assessment of quantitative perfusion parameters by dynamic contrast-enhanced sonography using a deconvolution method: an in vitro and in vivo study.
Gauthier M; Tabarout F; Leguerney I; Polrot M; Pitre S; Peronneau P; Lassau N
J Ultrasound Med; 2012 Apr; 31(4):595-608. PubMed ID: 22441917
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
[TBL] [Abstract][Full Text] [Related]
20. Study on breast cancer animal model of tumor-micro vessel variation before and after the chemotherapy by contrast enhanced ultrasound quantitative analysis.
Zhou SC; Le J; Fan YW; Chen M; Chang C
Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1407-13. PubMed ID: 27592472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
